nodes	percent_of_prediction	percent_of_DWPC	metapath
Fexofenadine—SLCO2B1—Estrone—prostate cancer	0.0824	0.107	CbGbCtD
Fexofenadine—SLCO1B3—Cabazitaxel—prostate cancer	0.0748	0.0975	CbGbCtD
Fexofenadine—SLCO2B1—Conjugated Estrogens—prostate cancer	0.0539	0.0702	CbGbCtD
Fexofenadine—SLCO1B3—Conjugated Estrogens—prostate cancer	0.0478	0.0624	CbGbCtD
Fexofenadine—SLCO2B1—Estradiol—prostate cancer	0.0473	0.0616	CbGbCtD
Fexofenadine—SLCO1A2—Estrone—prostate cancer	0.0451	0.0588	CbGbCtD
Fexofenadine—SLCO1B1—Cabazitaxel—prostate cancer	0.0436	0.0568	CbGbCtD
Fexofenadine—SLCO1B1—Estrone—prostate cancer	0.0426	0.0555	CbGbCtD
Fexofenadine—SLCO1B3—Estradiol—prostate cancer	0.042	0.0547	CbGbCtD
Fexofenadine—SLCO1A2—Conjugated Estrogens—prostate cancer	0.0295	0.0385	CbGbCtD
Fexofenadine—SLCO1B1—Conjugated Estrogens—prostate cancer	0.0279	0.0363	CbGbCtD
Fexofenadine—SLCO1A2—Estradiol—prostate cancer	0.0259	0.0338	CbGbCtD
Fexofenadine—SLCO1B3—Docetaxel—prostate cancer	0.0251	0.0327	CbGbCtD
Fexofenadine—SLCO1B1—Estradiol—prostate cancer	0.0245	0.0319	CbGbCtD
Fexofenadine—SLCO1A2—Prednisone—prostate cancer	0.0223	0.0291	CbGbCtD
Fexofenadine—CYP2D6—Bicalutamide—prostate cancer	0.0192	0.025	CbGbCtD
Fexofenadine—ABCB1—Estramustine—prostate cancer	0.0189	0.0247	CbGbCtD
Fexofenadine—CYP2D6—Abiraterone—prostate cancer	0.0159	0.0207	CbGbCtD
Fexofenadine—ABCB1—Cabazitaxel—prostate cancer	0.0125	0.0163	CbGbCtD
Fexofenadine—ABCB1—Estrone—prostate cancer	0.0122	0.0159	CbGbCtD
Fexofenadine—ABCB1—Ethinyl Estradiol—prostate cancer	0.0109	0.0142	CbGbCtD
Fexofenadine—ABCB1—Conjugated Estrogens—prostate cancer	0.00798	0.0104	CbGbCtD
Fexofenadine—ABCB1—Mitoxantrone—prostate cancer	0.00726	0.00946	CbGbCtD
Fexofenadine—ABCB1—Estradiol—prostate cancer	0.00701	0.00913	CbGbCtD
Fexofenadine—ABCB1—Prednisone—prostate cancer	0.00603	0.00785	CbGbCtD
Fexofenadine—ABCB1—Etoposide—prostate cancer	0.00458	0.00596	CbGbCtD
Fexofenadine—ABCB1—Docetaxel—prostate cancer	0.00419	0.00546	CbGbCtD
Fexofenadine—ABCB1—Doxorubicin—prostate cancer	0.00312	0.00407	CbGbCtD
Fexofenadine—CYP2D6—Doxorubicin—prostate cancer	0.00294	0.00383	CbGbCtD
Fexofenadine—CYP2D6—urine—prostate cancer	0.000413	0.128	CbGeAlD
Fexofenadine—Lomitapide—CYP3A4—prostate cancer	0.000361	0.165	CrCbGaD
Fexofenadine—SLCO2B1—prostate gland—prostate cancer	0.000346	0.107	CbGeAlD
Fexofenadine—SLCO1B1—renal system—prostate cancer	0.000267	0.0828	CbGeAlD
Fexofenadine—Pimozide—CYP3A5—prostate cancer	0.000238	0.109	CrCbGaD
Fexofenadine—SLCO2B1—renal system—prostate cancer	0.000236	0.0732	CbGeAlD
Fexofenadine—SLCO1A2—renal system—prostate cancer	0.000217	0.0674	CbGeAlD
Fexofenadine—Methadone—CYP2C18—prostate cancer	0.000215	0.0979	CrCbGaD
Fexofenadine—Fentanyl—CYP3A5—prostate cancer	0.000206	0.0941	CrCbGaD
Fexofenadine—HRH1—prostate gland—prostate cancer	0.000195	0.0605	CbGeAlD
Fexofenadine—Pimozide—CYP2E1—prostate cancer	0.000164	0.0746	CrCbGaD
Fexofenadine—Pimozide—CYP2C19—prostate cancer	0.000162	0.0739	CrCbGaD
Fexofenadine—Tachycardia—Mitoxantrone—prostate cancer	0.000157	0.00102	CcSEcCtD
Fexofenadine—Asthenia—Goserelin—prostate cancer	0.000156	0.00101	CcSEcCtD
Fexofenadine—Insomnia—Estradiol—prostate cancer	0.000156	0.00101	CcSEcCtD
Fexofenadine—Cardiac failure congestive—Doxorubicin—prostate cancer	0.000156	0.00101	CcSEcCtD
Fexofenadine—Asthenia—Conjugated Estrogens—prostate cancer	0.000155	0.001	CcSEcCtD
Fexofenadine—Pruritus—Goserelin—prostate cancer	0.000154	0.000996	CcSEcCtD
Fexofenadine—Dyspnoea—Estradiol—prostate cancer	0.000154	0.000995	CcSEcCtD
Fexofenadine—Somnolence—Estradiol—prostate cancer	0.000154	0.000992	CcSEcCtD
Fexofenadine—Pruritus—Conjugated Estrogens—prostate cancer	0.000153	0.000987	CcSEcCtD
Fexofenadine—Pain in extremity—Epirubicin—prostate cancer	0.000153	0.000987	CcSEcCtD
Fexofenadine—SLCO2B1—testis—prostate cancer	0.000153	0.0473	CbGeAlD
Fexofenadine—Dyspepsia—Estradiol—prostate cancer	0.000152	0.000983	CcSEcCtD
Fexofenadine—Increased appetite—Doxorubicin—prostate cancer	0.00015	0.000972	CcSEcCtD
Fexofenadine—Diarrhoea—Goserelin—prostate cancer	0.000149	0.000964	CcSEcCtD
Fexofenadine—Fatigue—Estradiol—prostate cancer	0.000149	0.000962	CcSEcCtD
Fexofenadine—Pain—Estradiol—prostate cancer	0.000148	0.000955	CcSEcCtD
Fexofenadine—Diarrhoea—Conjugated Estrogens—prostate cancer	0.000148	0.000954	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Mitoxantrone—prostate cancer	0.000147	0.000948	CcSEcCtD
Fexofenadine—Flushing—Docetaxel—prostate cancer	0.000145	0.000939	CcSEcCtD
Fexofenadine—Dizziness—Goserelin—prostate cancer	0.000144	0.000931	CcSEcCtD
Fexofenadine—Dyspnoea—Mitoxantrone—prostate cancer	0.000144	0.000927	CcSEcCtD
Fexofenadine—HRH1—epithelium—prostate cancer	0.000143	0.0445	CbGeAlD
Fexofenadine—Cough—Etoposide—prostate cancer	0.000143	0.000925	CcSEcCtD
Fexofenadine—Somnolence—Mitoxantrone—prostate cancer	0.000143	0.000925	CcSEcCtD
Fexofenadine—Dizziness—Conjugated Estrogens—prostate cancer	0.000143	0.000922	CcSEcCtD
Fexofenadine—Dyspepsia—Mitoxantrone—prostate cancer	0.000142	0.000916	CcSEcCtD
Fexofenadine—Methadone—CYP3A5—prostate cancer	0.000141	0.0645	CrCbGaD
Fexofenadine—Pain in extremity—Doxorubicin—prostate cancer	0.000141	0.000913	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Estradiol—prostate cancer	0.000141	0.000913	CcSEcCtD
Fexofenadine—Flushing—Capecitabine—prostate cancer	0.000141	0.000909	CcSEcCtD
Fexofenadine—SLCO1A2—testis—prostate cancer	0.00014	0.0436	CbGeAlD
Fexofenadine—Darifenacin—CYP3A4—prostate cancer	0.000139	0.0634	CrCbGaD
Fexofenadine—Fatigue—Mitoxantrone—prostate cancer	0.000139	0.000897	CcSEcCtD
Fexofenadine—Vomiting—Goserelin—prostate cancer	0.000139	0.000895	CcSEcCtD
Fexofenadine—Pain—Mitoxantrone—prostate cancer	0.000138	0.00089	CcSEcCtD
Fexofenadine—Rash—Goserelin—prostate cancer	0.000137	0.000888	CcSEcCtD
Fexofenadine—Dermatitis—Goserelin—prostate cancer	0.000137	0.000887	CcSEcCtD
Fexofenadine—Vomiting—Conjugated Estrogens—prostate cancer	0.000137	0.000887	CcSEcCtD
Fexofenadine—Urticaria—Estradiol—prostate cancer	0.000137	0.000887	CcSEcCtD
Fexofenadine—Body temperature increased—Estradiol—prostate cancer	0.000137	0.000883	CcSEcCtD
Fexofenadine—Abdominal pain—Estradiol—prostate cancer	0.000137	0.000883	CcSEcCtD
Fexofenadine—Nasopharyngitis—Epirubicin—prostate cancer	0.000137	0.000882	CcSEcCtD
Fexofenadine—Headache—Goserelin—prostate cancer	0.000137	0.000882	CcSEcCtD
Fexofenadine—Rash—Conjugated Estrogens—prostate cancer	0.000136	0.000879	CcSEcCtD
Fexofenadine—Dermatitis—Conjugated Estrogens—prostate cancer	0.000136	0.000879	CcSEcCtD
Fexofenadine—Headache—Conjugated Estrogens—prostate cancer	0.000135	0.000874	CcSEcCtD
Fexofenadine—Anaphylactic shock—Etoposide—prostate cancer	0.000134	0.000865	CcSEcCtD
Fexofenadine—Infection—Etoposide—prostate cancer	0.000133	0.00086	CcSEcCtD
Fexofenadine—Back pain—Docetaxel—prostate cancer	0.000132	0.000852	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Mitoxantrone—prostate cancer	0.000132	0.000851	CcSEcCtD
Fexofenadine—Tachycardia—Etoposide—prostate cancer	0.000131	0.000844	CcSEcCtD
Fexofenadine—HRH1—urethra—prostate cancer	0.000131	0.0405	CbGeAlD
Fexofenadine—Methadone—CYP19A1—prostate cancer	0.00013	0.0595	CrCbGaD
Fexofenadine—Flatulence—Capecitabine—prostate cancer	0.00013	0.000841	CcSEcCtD
Fexofenadine—Nausea—Goserelin—prostate cancer	0.000129	0.000836	CcSEcCtD
Fexofenadine—Nausea—Conjugated Estrogens—prostate cancer	0.000128	0.000829	CcSEcCtD
Fexofenadine—Urticaria—Mitoxantrone—prostate cancer	0.000128	0.000826	CcSEcCtD
Fexofenadine—Back pain—Capecitabine—prostate cancer	0.000128	0.000825	CcSEcCtD
Fexofenadine—Hypersensitivity—Estradiol—prostate cancer	0.000127	0.000822	CcSEcCtD
Fexofenadine—Abdominal pain—Mitoxantrone—prostate cancer	0.000127	0.000822	CcSEcCtD
Fexofenadine—Body temperature increased—Mitoxantrone—prostate cancer	0.000127	0.000822	CcSEcCtD
Fexofenadine—Nasopharyngitis—Doxorubicin—prostate cancer	0.000126	0.000816	CcSEcCtD
Fexofenadine—Flushing—Prednisone—prostate cancer	0.000125	0.00081	CcSEcCtD
Fexofenadine—Vision blurred—Capecitabine—prostate cancer	0.000124	0.000804	CcSEcCtD
Fexofenadine—Asthenia—Estradiol—prostate cancer	0.000124	0.000801	CcSEcCtD
Fexofenadine—Upper respiratory tract infection—Epirubicin—prostate cancer	0.000123	0.000793	CcSEcCtD
Fexofenadine—Pruritus—Estradiol—prostate cancer	0.000122	0.00079	CcSEcCtD
Fexofenadine—Pollakiuria—Epirubicin—prostate cancer	0.000122	0.000788	CcSEcCtD
Fexofenadine—Palpitations—Docetaxel—prostate cancer	0.000121	0.000779	CcSEcCtD
Fexofenadine—Dyspnoea—Etoposide—prostate cancer	0.000119	0.000771	CcSEcCtD
Fexofenadine—Somnolence—Etoposide—prostate cancer	0.000119	0.000769	CcSEcCtD
Fexofenadine—Cough—Docetaxel—prostate cancer	0.000119	0.000769	CcSEcCtD
Fexofenadine—Hypersensitivity—Mitoxantrone—prostate cancer	0.000119	0.000766	CcSEcCtD
Fexofenadine—Diarrhoea—Estradiol—prostate cancer	0.000118	0.000764	CcSEcCtD
Fexofenadine—Drowsiness—Epirubicin—prostate cancer	0.000118	0.00076	CcSEcCtD
Fexofenadine—Palpitations—Capecitabine—prostate cancer	0.000117	0.000754	CcSEcCtD
Fexofenadine—Myalgia—Docetaxel—prostate cancer	0.000116	0.00075	CcSEcCtD
Fexofenadine—Asthenia—Mitoxantrone—prostate cancer	0.000116	0.000746	CcSEcCtD
Fexofenadine—Fatigue—Etoposide—prostate cancer	0.000115	0.000746	CcSEcCtD
Fexofenadine—Cough—Capecitabine—prostate cancer	0.000115	0.000744	CcSEcCtD
Fexofenadine—Pain—Etoposide—prostate cancer	0.000115	0.00074	CcSEcCtD
Fexofenadine—Dizziness—Estradiol—prostate cancer	0.000114	0.000738	CcSEcCtD
Fexofenadine—Dry mouth—Docetaxel—prostate cancer	0.000114	0.000734	CcSEcCtD
Fexofenadine—Upper respiratory tract infection—Doxorubicin—prostate cancer	0.000114	0.000733	CcSEcCtD
Fexofenadine—Pollakiuria—Doxorubicin—prostate cancer	0.000113	0.000729	CcSEcCtD
Fexofenadine—Myalgia—Capecitabine—prostate cancer	0.000112	0.000726	CcSEcCtD
Fexofenadine—Anaphylactic shock—Docetaxel—prostate cancer	0.000111	0.000719	CcSEcCtD
Fexofenadine—Epistaxis—Epirubicin—prostate cancer	0.000111	0.000717	CcSEcCtD
Fexofenadine—Vision blurred—Prednisone—prostate cancer	0.000111	0.000716	CcSEcCtD
Fexofenadine—SLCO2B1—lymph node—prostate cancer	0.000111	0.0343	CbGeAlD
Fexofenadine—Infection—Docetaxel—prostate cancer	0.000111	0.000714	CcSEcCtD
Fexofenadine—Sinusitis—Epirubicin—prostate cancer	0.00011	0.000713	CcSEcCtD
Fexofenadine—Diarrhoea—Mitoxantrone—prostate cancer	0.00011	0.000712	CcSEcCtD
Fexofenadine—Dry mouth—Capecitabine—prostate cancer	0.00011	0.00071	CcSEcCtD
Fexofenadine—Vomiting—Estradiol—prostate cancer	0.00011	0.00071	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Etoposide—prostate cancer	0.00011	0.000708	CcSEcCtD
Fexofenadine—Rash—Estradiol—prostate cancer	0.000109	0.000704	CcSEcCtD
Fexofenadine—Drowsiness—Doxorubicin—prostate cancer	0.000109	0.000704	CcSEcCtD
Fexofenadine—Dermatitis—Estradiol—prostate cancer	0.000109	0.000703	CcSEcCtD
Fexofenadine—Tachycardia—Docetaxel—prostate cancer	0.000109	0.000702	CcSEcCtD
Fexofenadine—Headache—Estradiol—prostate cancer	0.000108	0.000699	CcSEcCtD
Fexofenadine—Agitation—Prednisone—prostate cancer	0.000108	0.000698	CcSEcCtD
Fexofenadine—Angioedema—Prednisone—prostate cancer	0.000107	0.000694	CcSEcCtD
Fexofenadine—Infection—Capecitabine—prostate cancer	0.000107	0.000692	CcSEcCtD
Fexofenadine—ABCB1—prostate gland—prostate cancer	0.000107	0.0331	CbGeAlD
Fexofenadine—Urticaria—Etoposide—prostate cancer	0.000106	0.000687	CcSEcCtD
Fexofenadine—Body temperature increased—Etoposide—prostate cancer	0.000106	0.000684	CcSEcCtD
Fexofenadine—Abdominal pain—Etoposide—prostate cancer	0.000106	0.000684	CcSEcCtD
Fexofenadine—Tachycardia—Capecitabine—prostate cancer	0.000105	0.000679	CcSEcCtD
Fexofenadine—Pimozide—CYP3A4—prostate cancer	0.000103	0.047	CrCbGaD
Fexofenadine—Epistaxis—Doxorubicin—prostate cancer	0.000103	0.000664	CcSEcCtD
Fexofenadine—Nausea—Estradiol—prostate cancer	0.000103	0.000663	CcSEcCtD
Fexofenadine—Vomiting—Mitoxantrone—prostate cancer	0.000102	0.000661	CcSEcCtD
Fexofenadine—Sinusitis—Doxorubicin—prostate cancer	0.000102	0.00066	CcSEcCtD
Fexofenadine—Rash—Mitoxantrone—prostate cancer	0.000102	0.000656	CcSEcCtD
Fexofenadine—Dermatitis—Mitoxantrone—prostate cancer	0.000101	0.000655	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Docetaxel—prostate cancer	0.000101	0.000655	CcSEcCtD
Fexofenadine—CYP2D6—renal system—prostate cancer	0.000101	0.0314	CbGeAlD
Fexofenadine—Headache—Mitoxantrone—prostate cancer	0.000101	0.000652	CcSEcCtD
Fexofenadine—Insomnia—Docetaxel—prostate cancer	0.000101	0.00065	CcSEcCtD
Fexofenadine—Myalgia—Prednisone—prostate cancer	0.0001	0.000647	CcSEcCtD
Fexofenadine—Dyspnoea—Docetaxel—prostate cancer	9.92e-05	0.000641	CcSEcCtD
Fexofenadine—Somnolence—Docetaxel—prostate cancer	9.89e-05	0.000639	CcSEcCtD
Fexofenadine—Hypersensitivity—Etoposide—prostate cancer	9.87e-05	0.000637	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Capecitabine—prostate cancer	9.82e-05	0.000634	CcSEcCtD
Fexofenadine—Flushing—Epirubicin—prostate cancer	9.81e-05	0.000634	CcSEcCtD
Fexofenadine—Dyspepsia—Docetaxel—prostate cancer	9.8e-05	0.000633	CcSEcCtD
Fexofenadine—Insomnia—Capecitabine—prostate cancer	9.75e-05	0.00063	CcSEcCtD
Fexofenadine—Methadone—CYP2C19—prostate cancer	9.63e-05	0.0439	CrCbGaD
Fexofenadine—Asthenia—Etoposide—prostate cancer	9.61e-05	0.000621	CcSEcCtD
Fexofenadine—Dyspnoea—Capecitabine—prostate cancer	9.61e-05	0.000621	CcSEcCtD
Fexofenadine—Anaphylactic shock—Prednisone—prostate cancer	9.6e-05	0.00062	CcSEcCtD
Fexofenadine—Fatigue—Docetaxel—prostate cancer	9.59e-05	0.00062	CcSEcCtD
Fexofenadine—Nausea—Mitoxantrone—prostate cancer	9.56e-05	0.000618	CcSEcCtD
Fexofenadine—Infection—Prednisone—prostate cancer	9.54e-05	0.000616	CcSEcCtD
Fexofenadine—Pain—Docetaxel—prostate cancer	9.52e-05	0.000615	CcSEcCtD
Fexofenadine—Dyspepsia—Capecitabine—prostate cancer	9.48e-05	0.000613	CcSEcCtD
Fexofenadine—Pruritus—Etoposide—prostate cancer	9.47e-05	0.000612	CcSEcCtD
Fexofenadine—Tachycardia—Prednisone—prostate cancer	9.37e-05	0.000605	CcSEcCtD
Fexofenadine—Fatigue—Capecitabine—prostate cancer	9.29e-05	0.0006	CcSEcCtD
Fexofenadine—Pain—Capecitabine—prostate cancer	9.21e-05	0.000595	CcSEcCtD
Fexofenadine—Diarrhoea—Etoposide—prostate cancer	9.16e-05	0.000592	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Docetaxel—prostate cancer	9.1e-05	0.000588	CcSEcCtD
Fexofenadine—Flushing—Doxorubicin—prostate cancer	9.07e-05	0.000586	CcSEcCtD
Fexofenadine—Flatulence—Epirubicin—prostate cancer	9.06e-05	0.000586	CcSEcCtD
Fexofenadine—ABCB1—seminal vesicle—prostate cancer	9.03e-05	0.028	CbGeAlD
Fexofenadine—Tension—Epirubicin—prostate cancer	9.03e-05	0.000583	CcSEcCtD
Fexofenadine—Nervousness—Epirubicin—prostate cancer	8.93e-05	0.000577	CcSEcCtD
Fexofenadine—Fentanyl—CYP3A4—prostate cancer	8.93e-05	0.0407	CrCbGaD
Fexofenadine—Back pain—Epirubicin—prostate cancer	8.9e-05	0.000575	CcSEcCtD
Fexofenadine—Dizziness—Etoposide—prostate cancer	8.86e-05	0.000572	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Capecitabine—prostate cancer	8.81e-05	0.000569	CcSEcCtD
Fexofenadine—Body temperature increased—Docetaxel—prostate cancer	8.8e-05	0.000568	CcSEcCtD
Fexofenadine—Abdominal pain—Docetaxel—prostate cancer	8.8e-05	0.000568	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Prednisone—prostate cancer	8.74e-05	0.000565	CcSEcCtD
Fexofenadine—Insomnia—Prednisone—prostate cancer	8.68e-05	0.000561	CcSEcCtD
Fexofenadine—Vision blurred—Epirubicin—prostate cancer	8.67e-05	0.00056	CcSEcCtD
Fexofenadine—Loperamide—CYP3A4—prostate cancer	8.6e-05	0.0392	CrCbGaD
Fexofenadine—HRH1—testis—prostate cancer	8.59e-05	0.0267	CbGeAlD
Fexofenadine—Urticaria—Capecitabine—prostate cancer	8.56e-05	0.000553	CcSEcCtD
Fexofenadine—Abdominal pain—Capecitabine—prostate cancer	8.52e-05	0.00055	CcSEcCtD
Fexofenadine—Body temperature increased—Capecitabine—prostate cancer	8.52e-05	0.00055	CcSEcCtD
Fexofenadine—Vomiting—Etoposide—prostate cancer	8.51e-05	0.00055	CcSEcCtD
Fexofenadine—Agitation—Epirubicin—prostate cancer	8.45e-05	0.000546	CcSEcCtD
Fexofenadine—Dyspepsia—Prednisone—prostate cancer	8.45e-05	0.000546	CcSEcCtD
Fexofenadine—Rash—Etoposide—prostate cancer	8.44e-05	0.000546	CcSEcCtD
Fexofenadine—Dermatitis—Etoposide—prostate cancer	8.44e-05	0.000545	CcSEcCtD
Fexofenadine—Headache—Etoposide—prostate cancer	8.39e-05	0.000542	CcSEcCtD
Fexofenadine—Flatulence—Doxorubicin—prostate cancer	8.39e-05	0.000542	CcSEcCtD
Fexofenadine—Tension—Doxorubicin—prostate cancer	8.35e-05	0.00054	CcSEcCtD
Fexofenadine—Fatigue—Prednisone—prostate cancer	8.27e-05	0.000535	CcSEcCtD
Fexofenadine—Nervousness—Doxorubicin—prostate cancer	8.27e-05	0.000534	CcSEcCtD
Fexofenadine—Back pain—Doxorubicin—prostate cancer	8.23e-05	0.000532	CcSEcCtD
Fexofenadine—Hypersensitivity—Docetaxel—prostate cancer	8.2e-05	0.00053	CcSEcCtD
Fexofenadine—Palpitations—Epirubicin—prostate cancer	8.13e-05	0.000525	CcSEcCtD
Fexofenadine—Cough—Epirubicin—prostate cancer	8.03e-05	0.000519	CcSEcCtD
Fexofenadine—Vision blurred—Doxorubicin—prostate cancer	8.02e-05	0.000518	CcSEcCtD
Fexofenadine—Asthenia—Docetaxel—prostate cancer	7.98e-05	0.000516	CcSEcCtD
Fexofenadine—Nausea—Etoposide—prostate cancer	7.95e-05	0.000514	CcSEcCtD
Fexofenadine—Hypersensitivity—Capecitabine—prostate cancer	7.94e-05	0.000513	CcSEcCtD
Fexofenadine—Pruritus—Docetaxel—prostate cancer	7.87e-05	0.000509	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Prednisone—prostate cancer	7.85e-05	0.000507	CcSEcCtD
Fexofenadine—ABCB1—epithelium—prostate cancer	7.84e-05	0.0243	CbGeAlD
Fexofenadine—Myalgia—Epirubicin—prostate cancer	7.83e-05	0.000506	CcSEcCtD
Fexofenadine—Agitation—Doxorubicin—prostate cancer	7.82e-05	0.000505	CcSEcCtD
Fexofenadine—Asthenia—Capecitabine—prostate cancer	7.73e-05	0.000499	CcSEcCtD
Fexofenadine—Dry mouth—Epirubicin—prostate cancer	7.66e-05	0.000495	CcSEcCtD
Fexofenadine—Urticaria—Prednisone—prostate cancer	7.62e-05	0.000493	CcSEcCtD
Fexofenadine—Pruritus—Capecitabine—prostate cancer	7.62e-05	0.000493	CcSEcCtD
Fexofenadine—Diarrhoea—Docetaxel—prostate cancer	7.61e-05	0.000492	CcSEcCtD
Fexofenadine—Abdominal pain—Prednisone—prostate cancer	7.59e-05	0.00049	CcSEcCtD
Fexofenadine—Body temperature increased—Prednisone—prostate cancer	7.59e-05	0.00049	CcSEcCtD
Fexofenadine—Palpitations—Doxorubicin—prostate cancer	7.52e-05	0.000486	CcSEcCtD
Fexofenadine—Anaphylactic shock—Epirubicin—prostate cancer	7.51e-05	0.000485	CcSEcCtD
Fexofenadine—Infection—Epirubicin—prostate cancer	7.46e-05	0.000482	CcSEcCtD
Fexofenadine—Cough—Doxorubicin—prostate cancer	7.43e-05	0.00048	CcSEcCtD
Fexofenadine—Diarrhoea—Capecitabine—prostate cancer	7.37e-05	0.000476	CcSEcCtD
Fexofenadine—Dizziness—Docetaxel—prostate cancer	7.36e-05	0.000475	CcSEcCtD
Fexofenadine—Tachycardia—Epirubicin—prostate cancer	7.33e-05	0.000473	CcSEcCtD
Fexofenadine—ABCB1—renal system—prostate cancer	7.28e-05	0.0226	CbGeAlD
Fexofenadine—Myalgia—Doxorubicin—prostate cancer	7.25e-05	0.000468	CcSEcCtD
Fexofenadine—ABCB1—urethra—prostate cancer	7.15e-05	0.0222	CbGeAlD
Fexofenadine—Dizziness—Capecitabine—prostate cancer	7.13e-05	0.00046	CcSEcCtD
Fexofenadine—Dry mouth—Doxorubicin—prostate cancer	7.09e-05	0.000458	CcSEcCtD
Fexofenadine—Vomiting—Docetaxel—prostate cancer	7.08e-05	0.000457	CcSEcCtD
Fexofenadine—Hypersensitivity—Prednisone—prostate cancer	7.07e-05	0.000457	CcSEcCtD
Fexofenadine—Rash—Docetaxel—prostate cancer	7.02e-05	0.000453	CcSEcCtD
Fexofenadine—Dermatitis—Docetaxel—prostate cancer	7.01e-05	0.000453	CcSEcCtD
Fexofenadine—Headache—Docetaxel—prostate cancer	6.97e-05	0.00045	CcSEcCtD
Fexofenadine—Anaphylactic shock—Doxorubicin—prostate cancer	6.95e-05	0.000449	CcSEcCtD
Fexofenadine—Infection—Doxorubicin—prostate cancer	6.9e-05	0.000446	CcSEcCtD
Fexofenadine—Asthenia—Prednisone—prostate cancer	6.89e-05	0.000445	CcSEcCtD
Fexofenadine—Vomiting—Capecitabine—prostate cancer	6.85e-05	0.000443	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Epirubicin—prostate cancer	6.84e-05	0.000442	CcSEcCtD
Fexofenadine—Rash—Capecitabine—prostate cancer	6.79e-05	0.000439	CcSEcCtD
Fexofenadine—Pruritus—Prednisone—prostate cancer	6.79e-05	0.000439	CcSEcCtD
Fexofenadine—Insomnia—Epirubicin—prostate cancer	6.79e-05	0.000439	CcSEcCtD
Fexofenadine—Dermatitis—Capecitabine—prostate cancer	6.79e-05	0.000439	CcSEcCtD
Fexofenadine—Tachycardia—Doxorubicin—prostate cancer	6.78e-05	0.000438	CcSEcCtD
Fexofenadine—Headache—Capecitabine—prostate cancer	6.75e-05	0.000436	CcSEcCtD
Fexofenadine—Dyspnoea—Epirubicin—prostate cancer	6.69e-05	0.000432	CcSEcCtD
Fexofenadine—Somnolence—Epirubicin—prostate cancer	6.67e-05	0.000431	CcSEcCtD
Fexofenadine—Nausea—Docetaxel—prostate cancer	6.61e-05	0.000427	CcSEcCtD
Fexofenadine—Dyspepsia—Epirubicin—prostate cancer	6.61e-05	0.000427	CcSEcCtD
Fexofenadine—Diarrhoea—Prednisone—prostate cancer	6.57e-05	0.000424	CcSEcCtD
Fexofenadine—CYP2D6—testis—prostate cancer	6.54e-05	0.0203	CbGeAlD
Fexofenadine—Fatigue—Epirubicin—prostate cancer	6.47e-05	0.000418	CcSEcCtD
Fexofenadine—Pain—Epirubicin—prostate cancer	6.42e-05	0.000415	CcSEcCtD
Fexofenadine—Nausea—Capecitabine—prostate cancer	6.4e-05	0.000414	CcSEcCtD
Fexofenadine—Dizziness—Prednisone—prostate cancer	6.35e-05	0.00041	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Doxorubicin—prostate cancer	6.33e-05	0.000409	CcSEcCtD
Fexofenadine—Insomnia—Doxorubicin—prostate cancer	6.28e-05	0.000406	CcSEcCtD
Fexofenadine—HRH1—lymph node—prostate cancer	6.23e-05	0.0193	CbGeAlD
Fexofenadine—Dyspnoea—Doxorubicin—prostate cancer	6.19e-05	0.0004	CcSEcCtD
Fexofenadine—Somnolence—Doxorubicin—prostate cancer	6.17e-05	0.000399	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Epirubicin—prostate cancer	6.14e-05	0.000397	CcSEcCtD
Fexofenadine—Methadone—CYP3A4—prostate cancer	6.12e-05	0.0279	CrCbGaD
Fexofenadine—Dyspepsia—Doxorubicin—prostate cancer	6.11e-05	0.000395	CcSEcCtD
Fexofenadine—Vomiting—Prednisone—prostate cancer	6.1e-05	0.000394	CcSEcCtD
Fexofenadine—Rash—Prednisone—prostate cancer	6.05e-05	0.000391	CcSEcCtD
Fexofenadine—Dermatitis—Prednisone—prostate cancer	6.05e-05	0.000391	CcSEcCtD
Fexofenadine—Headache—Prednisone—prostate cancer	6.01e-05	0.000388	CcSEcCtD
Fexofenadine—Fatigue—Doxorubicin—prostate cancer	5.99e-05	0.000387	CcSEcCtD
Fexofenadine—Urticaria—Epirubicin—prostate cancer	5.96e-05	0.000385	CcSEcCtD
Fexofenadine—Pain—Doxorubicin—prostate cancer	5.94e-05	0.000384	CcSEcCtD
Fexofenadine—Body temperature increased—Epirubicin—prostate cancer	5.93e-05	0.000383	CcSEcCtD
Fexofenadine—Abdominal pain—Epirubicin—prostate cancer	5.93e-05	0.000383	CcSEcCtD
Fexofenadine—Nausea—Prednisone—prostate cancer	5.7e-05	0.000368	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Doxorubicin—prostate cancer	5.68e-05	0.000367	CcSEcCtD
Fexofenadine—Hypersensitivity—Epirubicin—prostate cancer	5.53e-05	0.000357	CcSEcCtD
Fexofenadine—Urticaria—Doxorubicin—prostate cancer	5.52e-05	0.000357	CcSEcCtD
Fexofenadine—ABCB1—bone marrow—prostate cancer	5.5e-05	0.0171	CbGeAlD
Fexofenadine—Body temperature increased—Doxorubicin—prostate cancer	5.49e-05	0.000355	CcSEcCtD
Fexofenadine—Abdominal pain—Doxorubicin—prostate cancer	5.49e-05	0.000355	CcSEcCtD
Fexofenadine—Asthenia—Epirubicin—prostate cancer	5.39e-05	0.000348	CcSEcCtD
Fexofenadine—Pruritus—Epirubicin—prostate cancer	5.31e-05	0.000343	CcSEcCtD
Fexofenadine—Diarrhoea—Epirubicin—prostate cancer	5.14e-05	0.000332	CcSEcCtD
Fexofenadine—Hypersensitivity—Doxorubicin—prostate cancer	5.12e-05	0.000331	CcSEcCtD
Fexofenadine—Asthenia—Doxorubicin—prostate cancer	4.98e-05	0.000322	CcSEcCtD
Fexofenadine—Dizziness—Epirubicin—prostate cancer	4.96e-05	0.000321	CcSEcCtD
Fexofenadine—Pruritus—Doxorubicin—prostate cancer	4.91e-05	0.000317	CcSEcCtD
Fexofenadine—Vomiting—Epirubicin—prostate cancer	4.77e-05	0.000308	CcSEcCtD
Fexofenadine—Diarrhoea—Doxorubicin—prostate cancer	4.75e-05	0.000307	CcSEcCtD
Fexofenadine—Rash—Epirubicin—prostate cancer	4.73e-05	0.000306	CcSEcCtD
Fexofenadine—Dermatitis—Epirubicin—prostate cancer	4.73e-05	0.000306	CcSEcCtD
Fexofenadine—ABCB1—testis—prostate cancer	4.7e-05	0.0146	CbGeAlD
Fexofenadine—Headache—Epirubicin—prostate cancer	4.7e-05	0.000304	CcSEcCtD
Fexofenadine—Dizziness—Doxorubicin—prostate cancer	4.59e-05	0.000297	CcSEcCtD
Fexofenadine—Nausea—Epirubicin—prostate cancer	4.46e-05	0.000288	CcSEcCtD
Fexofenadine—Vomiting—Doxorubicin—prostate cancer	4.42e-05	0.000285	CcSEcCtD
Fexofenadine—Rash—Doxorubicin—prostate cancer	4.38e-05	0.000283	CcSEcCtD
Fexofenadine—Dermatitis—Doxorubicin—prostate cancer	4.38e-05	0.000283	CcSEcCtD
Fexofenadine—Headache—Doxorubicin—prostate cancer	4.35e-05	0.000281	CcSEcCtD
Fexofenadine—Nausea—Doxorubicin—prostate cancer	4.13e-05	0.000267	CcSEcCtD
Fexofenadine—ABCB1—lymph node—prostate cancer	3.41e-05	0.0106	CbGeAlD
Fexofenadine—HRH1—Signaling Pathways—TGFBR1—prostate cancer	8.91e-06	0.000123	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PTHLH—prostate cancer	8.91e-06	0.000123	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—prostate cancer	8.89e-06	0.000123	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—PPARA—prostate cancer	8.87e-06	0.000122	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—GSTO1—prostate cancer	8.86e-06	0.000122	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—HSD3B2—prostate cancer	8.86e-06	0.000122	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—NAT2—prostate cancer	8.86e-06	0.000122	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—TYMS—prostate cancer	8.85e-06	0.000122	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—AKR1C3—prostate cancer	8.76e-06	0.000121	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—GSTA2—prostate cancer	8.75e-06	0.000121	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—GSTM1—prostate cancer	8.74e-06	0.000121	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PRKACB—prostate cancer	8.72e-06	0.00012	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—SULT1A1—prostate cancer	8.65e-06	0.000119	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—ABCG5—prostate cancer	8.65e-06	0.000119	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—LPL—prostate cancer	8.58e-06	0.000118	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PPP3CA—prostate cancer	8.5e-06	0.000117	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—THBS1—prostate cancer	8.5e-06	0.000117	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PLCB2—prostate cancer	8.5e-06	0.000117	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—LRP2—prostate cancer	8.5e-06	0.000117	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—CYP2C18—prostate cancer	8.5e-06	0.000117	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—PIK3CD—prostate cancer	8.49e-06	0.000117	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—GSTA1—prostate cancer	8.45e-06	0.000116	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—ANXA1—prostate cancer	8.38e-06	0.000115	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—GSTO1—prostate cancer	8.35e-06	0.000115	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—HSD3B2—prostate cancer	8.35e-06	0.000115	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—NAT2—prostate cancer	8.35e-06	0.000115	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—CAV1—prostate cancer	8.34e-06	0.000115	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—P4HB—prostate cancer	8.33e-06	0.000115	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—CYP1A1—prostate cancer	8.29e-06	0.000114	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PRKCZ—prostate cancer	8.22e-06	0.000113	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—ERCC2—prostate cancer	8.22e-06	0.000113	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—prostate cancer	8.16e-06	0.000113	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—SLC22A1—prostate cancer	8.11e-06	0.000112	CbGpPWpGaD
Fexofenadine—ABCB1—Transmembrane transport of small molecules—PPARA—prostate cancer	8.1e-06	0.000112	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—PIK3CG—prostate cancer	8.04e-06	0.000111	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—NOS3—prostate cancer	8.02e-06	0.000111	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PLCB2—prostate cancer	8.01e-06	0.00011	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—LRP2—prostate cancer	8.01e-06	0.00011	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—CYP2C18—prostate cancer	8.01e-06	0.00011	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	7.96e-06	0.00011	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PARP1—prostate cancer	7.94e-06	0.000109	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—FGFR4—prostate cancer	7.94e-06	0.000109	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—SULT2A1—prostate cancer	7.9e-06	0.000109	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—prostate cancer	7.9e-06	0.000109	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—P4HB—prostate cancer	7.85e-06	0.000108	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CALCA—prostate cancer	7.84e-06	0.000108	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—MED12—prostate cancer	7.77e-06	0.000107	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—MTHFR—prostate cancer	7.73e-06	0.000107	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—GNG5—prostate cancer	7.71e-06	0.000106	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CXCL12—prostate cancer	7.66e-06	0.000106	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—SLC22A1—prostate cancer	7.64e-06	0.000105	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—PIK3CG—prostate cancer	7.59e-06	0.000105	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—PPARA—prostate cancer	7.58e-06	0.000105	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—SULT2A1—prostate cancer	7.44e-06	0.000103	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—NCOA3—prostate cancer	7.43e-06	0.000102	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—PIK3CB—prostate cancer	7.4e-06	0.000102	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—PTGS2—prostate cancer	7.34e-06	0.000101	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—MED12—prostate cancer	7.32e-06	0.000101	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—PIK3CG—prostate cancer	7.3e-06	0.000101	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—GNG5—prostate cancer	7.27e-06	0.0001	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CASP9—prostate cancer	7.21e-06	9.95e-05	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—INS—prostate cancer	7.19e-06	9.91e-05	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—CAV1—prostate cancer	7.13e-06	9.83e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—HPGDS—prostate cancer	7.09e-06	9.77e-05	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—PIK3CD—prostate cancer	7.06e-06	9.74e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—CYP2C19—prostate cancer	7.04e-06	9.71e-05	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—CREBBP—prostate cancer	7.04e-06	9.71e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—NCOA3—prostate cancer	7e-06	9.65e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—NGFR—prostate cancer	6.99e-06	9.64e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PRKCQ—prostate cancer	6.99e-06	9.64e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—MAP3K7—prostate cancer	6.91e-06	9.52e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—GSTT1—prostate cancer	6.87e-06	9.47e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—ACHE—prostate cancer	6.87e-06	9.47e-05	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	6.81e-06	9.39e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—CYP2A6—prostate cancer	6.79e-06	9.37e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—HPGDS—prostate cancer	6.68e-06	9.21e-05	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—PIK3CD—prostate cancer	6.67e-06	9.2e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—prostate cancer	6.67e-06	9.19e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—FGF10—prostate cancer	6.64e-06	9.16e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—CYP2C19—prostate cancer	6.63e-06	9.15e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—AKR1C3—prostate cancer	6.61e-06	9.11e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PRKACB—prostate cancer	6.57e-06	9.06e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—ADRB2—prostate cancer	6.57e-06	9.06e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—CYP17A1—prostate cancer	6.5e-06	8.97e-05	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—PIK3CG—prostate cancer	6.49e-06	8.95e-05	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—JAK2—prostate cancer	6.48e-06	8.94e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—ACHE—prostate cancer	6.48e-06	8.93e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—GSTT1—prostate cancer	6.48e-06	8.93e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—MAP2K1—prostate cancer	6.46e-06	8.9e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Transmembrane transport of small molecules—CREBBP—prostate cancer	6.43e-06	8.87e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—PIK3CD—prostate cancer	6.41e-06	8.84e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—VAV3—prostate cancer	6.41e-06	8.84e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—CYP2A6—prostate cancer	6.4e-06	8.83e-05	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—PTEN—prostate cancer	6.4e-06	8.82e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—TGFBR2—prostate cancer	6.32e-06	8.71e-05	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—NOS3—prostate cancer	6.3e-06	8.69e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—AKR1C3—prostate cancer	6.23e-06	8.59e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—ITPR1—prostate cancer	6.22e-06	8.57e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—NCOA2—prostate cancer	6.2e-06	8.55e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PRKACB—prostate cancer	6.19e-06	8.54e-05	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—PIK3CB—prostate cancer	6.16e-06	8.49e-05	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—INS—prostate cancer	6.15e-06	8.47e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—CYP17A1—prostate cancer	6.13e-06	8.45e-05	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—EP300—prostate cancer	6.1e-06	8.41e-05	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—CREBBP—prostate cancer	6.02e-06	8.3e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—IGF1R—prostate cancer	5.94e-06	8.19e-05	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—CXCL8—prostate cancer	5.92e-06	8.16e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—SLC5A5—prostate cancer	5.91e-06	8.15e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—JAK2—prostate cancer	5.89e-06	8.12e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—NCOA2—prostate cancer	5.84e-06	8.05e-05	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—PIK3CB—prostate cancer	5.82e-06	8.02e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—CYP2E1—prostate cancer	5.78e-06	7.96e-05	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—PTGS2—prostate cancer	5.76e-06	7.95e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—NQO1—prostate cancer	5.71e-06	7.87e-05	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—PIK3CD—prostate cancer	5.71e-06	7.87e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—LPL—prostate cancer	5.7e-06	7.86e-05	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—IL2—prostate cancer	5.65e-06	7.8e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PDGFRB—prostate cancer	5.65e-06	7.79e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—TH—prostate cancer	5.63e-06	7.76e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—PIK3CB—prostate cancer	5.59e-06	7.71e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—SLC5A5—prostate cancer	5.57e-06	7.68e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—CYP3A4—prostate cancer	5.57e-06	7.68e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—ITGB3—prostate cancer	5.5e-06	7.59e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—CYP1B1—prostate cancer	5.48e-06	7.55e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—CYP2E1—prostate cancer	5.44e-06	7.5e-05	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—NOS3—prostate cancer	5.39e-06	7.43e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—NQO1—prostate cancer	5.38e-06	7.42e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—CXCL8—prostate cancer	5.37e-06	7.41e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—ERBB3—prostate cancer	5.34e-06	7.36e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—FGFR2—prostate cancer	5.33e-06	7.35e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—TH—prostate cancer	5.3e-06	7.31e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—GGT1—prostate cancer	5.3e-06	7.31e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—CYP3A4—prostate cancer	5.25e-06	7.24e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—NCOA1—prostate cancer	5.22e-06	7.2e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—CYP1B1—prostate cancer	5.16e-06	7.11e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—CYP19A1—prostate cancer	5.15e-06	7.1e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—IL2—prostate cancer	5.14e-06	7.08e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—TERT—prostate cancer	5.12e-06	7.05e-05	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—PTEN—prostate cancer	5.03e-06	6.93e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—GGT1—prostate cancer	5e-06	6.89e-05	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—PIK3CB—prostate cancer	4.97e-06	6.86e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—RXRA—prostate cancer	4.97e-06	6.85e-05	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—PTGS2—prostate cancer	4.93e-06	6.8e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—NCOA1—prostate cancer	4.92e-06	6.79e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—HIF1A—prostate cancer	4.89e-06	6.75e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—CYP19A1—prostate cancer	4.85e-06	6.69e-05	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—EP300—prostate cancer	4.79e-06	6.61e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—COMT—prostate cancer	4.79e-06	6.6e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—LEP—prostate cancer	4.78e-06	6.59e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—GSTP1—prostate cancer	4.76e-06	6.57e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CAV1—prostate cancer	4.73e-06	6.52e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—ITPR1—prostate cancer	4.69e-06	6.46e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—RXRA—prostate cancer	4.68e-06	6.45e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—KDR—prostate cancer	4.68e-06	6.45e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—ESR1—prostate cancer	4.56e-06	6.29e-05	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—PIK3CA—prostate cancer	4.51e-06	6.22e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—COMT—prostate cancer	4.51e-06	6.22e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—GSTP1—prostate cancer	4.49e-06	6.19e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—BAD—prostate cancer	4.45e-06	6.14e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—TYMS—prostate cancer	4.43e-06	6.11e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—ITPR1—prostate cancer	4.42e-06	6.09e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—GSTM1—prostate cancer	4.38e-06	6.03e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PIK3CG—prostate cancer	4.31e-06	5.94e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—APC—prostate cancer	4.31e-06	5.94e-05	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—PTEN—prostate cancer	4.3e-06	5.93e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—LPL—prostate cancer	4.3e-06	5.92e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—EGF—prostate cancer	4.26e-06	5.87e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—IRS1—prostate cancer	4.26e-06	5.87e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—TYMS—prostate cancer	4.17e-06	5.75e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—CYP1A1—prostate cancer	4.15e-06	5.72e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—GSK3B—prostate cancer	4.14e-06	5.7e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—GSTM1—prostate cancer	4.12e-06	5.69e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—ERCC2—prostate cancer	4.12e-06	5.67e-05	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—EP300—prostate cancer	4.1e-06	5.65e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—INS—prostate cancer	4.08e-06	5.63e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—LPL—prostate cancer	4.05e-06	5.58e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CREBBP—prostate cancer	4e-06	5.51e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—IGF1—prostate cancer	3.95e-06	5.44e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—EGFR—prostate cancer	3.93e-06	5.41e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—CYP1A1—prostate cancer	3.91e-06	5.39e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—ERCC2—prostate cancer	3.88e-06	5.35e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—MTHFR—prostate cancer	3.87e-06	5.33e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—MAP2K1—prostate cancer	3.81e-06	5.26e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PPARA—prostate cancer	3.8e-06	5.23e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PIK3CD—prostate cancer	3.79e-06	5.22e-05	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—PIK3CA—prostate cancer	3.75e-06	5.18e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—SERPINE1—prostate cancer	3.75e-06	5.17e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—KRAS—prostate cancer	3.71e-06	5.12e-05	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—AKT1—prostate cancer	3.69e-06	5.08e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—MTHFR—prostate cancer	3.65e-06	5.03e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—FGF2—prostate cancer	3.63e-06	5e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—NOS3—prostate cancer	3.58e-06	4.93e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PPARA—prostate cancer	3.58e-06	4.93e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—CAV1—prostate cancer	3.57e-06	4.92e-05	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—PIK3CA—prostate cancer	3.55e-06	4.89e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—JAK2—prostate cancer	3.48e-06	4.79e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—PIK3CA—prostate cancer	3.41e-06	4.7e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—MDM2—prostate cancer	3.39e-06	4.68e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—CAV1—prostate cancer	3.36e-06	4.64e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—ERBB2—prostate cancer	3.35e-06	4.61e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PIK3CB—prostate cancer	3.3e-06	4.55e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PIK3CG—prostate cancer	3.25e-06	4.48e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CXCL8—prostate cancer	3.17e-06	4.38e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CDKN1B—prostate cancer	3.1e-06	4.27e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—INS—prostate cancer	3.08e-06	4.24e-05	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—AKT1—prostate cancer	3.07e-06	4.23e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PIK3CG—prostate cancer	3.06e-06	4.22e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CASP3—prostate cancer	3.04e-06	4.19e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—IL2—prostate cancer	3.03e-06	4.18e-05	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—PIK3CA—prostate cancer	3.03e-06	4.18e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—IL6—prostate cancer	3.02e-06	4.16e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—CREBBP—prostate cancer	3.01e-06	4.15e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CCND1—prostate cancer	2.96e-06	4.08e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CTNNB1—prostate cancer	2.93e-06	4.04e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—INS—prostate cancer	2.9e-06	4e-05	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—AKT1—prostate cancer	2.9e-06	3.99e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—MMP9—prostate cancer	2.87e-06	3.96e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CDKN1A—prostate cancer	2.86e-06	3.94e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PIK3CD—prostate cancer	2.86e-06	3.94e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PTEN—prostate cancer	2.85e-06	3.94e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—CREBBP—prostate cancer	2.84e-06	3.92e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—AKT1—prostate cancer	2.78e-06	3.84e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—EP300—prostate cancer	2.72e-06	3.75e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—NOS3—prostate cancer	2.7e-06	3.72e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PIK3CD—prostate cancer	2.69e-06	3.71e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—SRC—prostate cancer	2.65e-06	3.65e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—VEGFA—prostate cancer	2.58e-06	3.55e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—STAT3—prostate cancer	2.55e-06	3.52e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—NOS3—prostate cancer	2.54e-06	3.51e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PIK3CB—prostate cancer	2.49e-06	3.43e-05	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—AKT1—prostate cancer	2.48e-06	3.42e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PTGS2—prostate cancer	2.47e-06	3.4e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—MYC—prostate cancer	2.37e-06	3.27e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—TGFB1—prostate cancer	2.37e-06	3.26e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PIK3CB—prostate cancer	2.35e-06	3.24e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PTGS2—prostate cancer	2.33e-06	3.21e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—EGFR—prostate cancer	2.32e-06	3.2e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—KRAS—prostate cancer	2.19e-06	3.02e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PTEN—prostate cancer	2.15e-06	2.97e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—EP300—prostate cancer	2.05e-06	2.83e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PTEN—prostate cancer	2.03e-06	2.8e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PIK3CA—prostate cancer	2.01e-06	2.78e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—TP53—prostate cancer	1.95e-06	2.69e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—EP300—prostate cancer	1.93e-06	2.67e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—IL6—prostate cancer	1.78e-06	2.46e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—AKT1—prostate cancer	1.64e-06	2.27e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PIK3CA—prostate cancer	1.52e-06	2.09e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PIK3CA—prostate cancer	1.43e-06	1.97e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—AKT1—prostate cancer	1.24e-06	1.71e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—AKT1—prostate cancer	1.17e-06	1.61e-05	CbGpPWpGaD
